Market Cap

Immunic, Inc. Market Capitalization:

$69.7 Million

USD as of July 1, 2025

business Immunic, Inc. Company Profile

Immunic, Inc. Main Stock Listing

NASDAQ: IMUX

Market Capitalization History of Immunic, Inc.

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Immunic, Inc. market cap

Date Market Cap YoY Change
Jan. 1, 2025 $89.4 M 42.49%
Jan. 1, 2024 $62.8 M -6.31%
Jan. 1, 2023 $67.0 M -87.28%
Jan. 1, 2022 $526.5 M -28.80%
Jan. 1, 2021 $739.5 M 98.32%
Jan. 1, 2020 $372.9 M -5.11%
Jan. 1, 2019 $393.0 M -96.30%
Jan. 1, 2018 $10.63 B 20.20%
Jan. 1, 2017 $8.84 B -45.90%
Jan. 1, 2016 $16.34 B -53.65%
Jan. 1, 2015 $35.26 B

Market capitalization is calculated from the opening stock price at the beginning of each year.

⛩️ Moltgate
Spam is free. Your attention isn’t.
Turn your inbox into a paid channel. Set your price lanes $10 / $30 / $100 and only get messages worth reading.
Get Started Free
Built for busy humans + 🦞 AI agents. Plain-text only.

Immunic, Inc. Categories

United States languages Healthcare languages Biotechnology
United States Healthcare United States Biotechnology

Stocks & Indices

Immunic, Inc. has the following listings and related stock indices.


Stock: NASDAQ: IMUX

Stock: FSX: 10VA

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.